212 related articles for article (PubMed ID: 32599298)
1. Post-translational modifications contribute to neoepitopes in Type-1 diabetes: Challenges for inducing antigen-specific tolerance.
Balakrishnan S; Kumar P; Prabhakar BS
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140478. PubMed ID: 32599298
[TBL] [Abstract][Full Text] [Related]
2. Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets.
Rodriguez-Calvo T; Johnson JD; Overbergh L; Dunne JL
Front Immunol; 2021; 12():667989. PubMed ID: 33953728
[TBL] [Abstract][Full Text] [Related]
3. Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes.
Mannering SI; Di Carluccio AR; Elso CM
Diabetologia; 2019 Mar; 62(3):351-356. PubMed ID: 30402774
[TBL] [Abstract][Full Text] [Related]
4. Immune Recognition of β-Cells: Neoepitopes as Key Players in the Loss of Tolerance.
James EA; Pietropaolo M; Mamula MJ
Diabetes; 2018 Jun; 67(6):1035-1042. PubMed ID: 29784651
[TBL] [Abstract][Full Text] [Related]
5. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4
Marre ML; McGinty JW; Chow IT; DeNicola ME; Beck NW; Kent SC; Powers AC; Bottino R; Harlan DM; Greenbaum CJ; Kwok WW; Piganelli JD; James EA
Diabetes; 2018 Jul; 67(7):1356-1368. PubMed ID: 29654212
[TBL] [Abstract][Full Text] [Related]
6. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
7. Mapping T Cell Responses to Native and Neo-Islet Antigen Epitopes in at Risk and Type 1 Diabetes Subjects.
Arif S; Pujol-Autonell I; Kamra Y; Williams E; Yusuf N; Domingo-Vila C; Shahrabi Y; Pollock E; Khatri L; Peakman M; Tree T; Lorenc A
Front Immunol; 2021; 12():675746. PubMed ID: 34262563
[TBL] [Abstract][Full Text] [Related]
8. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive T cells in type 1 diabetes.
Pugliese A
J Clin Invest; 2017 Aug; 127(8):2881-2891. PubMed ID: 28762987
[TBL] [Abstract][Full Text] [Related]
10. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
11. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure?
Dunne JL; Overbergh L; Purcell AW; Mathieu C
Diabetes; 2012 Aug; 61(8):1907-14. PubMed ID: 22826307
[TBL] [Abstract][Full Text] [Related]
13. Human islets and dendritic cells generate post-translationally modified islet autoantigens.
McLaughlin RJ; de Haan A; Zaldumbide A; de Koning EJ; de Ru AH; van Veelen PA; van Lummel M; Roep BO
Clin Exp Immunol; 2016 Aug; 185(2):133-40. PubMed ID: 26861694
[TBL] [Abstract][Full Text] [Related]
14. Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes.
Mannering SI; Rubin AF; Wang R; Bhattacharjee P
Front Immunol; 2021; 12():667870. PubMed ID: 33995402
[TBL] [Abstract][Full Text] [Related]
15. T cell epitopes and post-translationally modified epitopes in type 1 diabetes.
McGinty JW; Marré ML; Bajzik V; Piganelli JD; James EA
Curr Diab Rep; 2015 Nov; 15(11):90. PubMed ID: 26370701
[TBL] [Abstract][Full Text] [Related]
16. Autoantigen-specific memory CD4+ T cells are prevalent early in progression to Type 1 diabetes.
Oling V; Reijonen H; Simell O; Knip M; Ilonen J
Cell Immunol; 2012; 273(2):133-9. PubMed ID: 22270037
[TBL] [Abstract][Full Text] [Related]
17. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
18. A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes.
Roep BO; Kracht MJ; van Lummel M; Zaldumbide A
Curr Opin Immunol; 2016 Dec; 43():67-73. PubMed ID: 27723537
[TBL] [Abstract][Full Text] [Related]
19. The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes.
Purcell AW; Sechi S; DiLorenzo TP
Diabetes; 2019 May; 68(5):879-886. PubMed ID: 31010879
[TBL] [Abstract][Full Text] [Related]
20. Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells.
Leon MA; Wemlinger SM; Larson NR; Ruffalo JK; Sestak JO; Middaugh CR; Cambier JC; Berkland C
Mol Pharm; 2019 Apr; 16(4):1563-1572. PubMed ID: 30681867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
